Procainamide Hydrochloride (Nexus Pharmaceuticals Inc)
Welcome to the PulseAid listing for the Procainamide Hydrochloride drug offered from Nexus Pharmaceuticals Inc. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Nexus Pharmaceuticals Inc |
NON-PROPRIETARY NAME: | Procainamide Hydrochloride |
SUBSTANCE NAME: | PROCAINAMIDE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antiarrhythmic [EPC] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-10-18 |
END MARKETING DATE: | 0000-00-00 |
Procainamide Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Procainamide Hydrochloride from Nexus Pharmaceuticals Inc |
LABELER NAME: | Nexus Pharmaceuticals Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1000(mg/1) |
START MARKETING DATE: | 2017-10-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 14789-900_c500fb74-4285-4756-aa0d-c6da775f72b4 |
PRODUCT NDC: | 14789-900 |
APPLICATION NUMBER: | ANDA206332 |
Other PROCAINAMIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: